← ANALYSTS · TIPRANKS
Ami Fadia · Needham
Hits
59%
297 of 500 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+36.1%
Over a year after the rating, TipRanks’ measure
Our companies rated now
15
Buy / hold / sell: 14 / 1 / 0
Upside of the analyst’s targets
+181.9%
Average over 14 current targets, to the last price
The market’s answer to the ratings
−0.3%
Day-0 move against SPY in the rating’s direction, average over 6 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 16on TipRanks 07:35 | NBIXNeurocrine · $13.9B | Reiterated | Buy | $204 | +50.3% | +0.2% | ↗ |
| Oct 16on TipRanks 07:35 | JAZZJazz Pharmaceuticals · $13.9B | Reiterated | Buy | $310 | +47.5% | −0.8% | ↗ |
| Oct 15on TipRanks 07:30 | RVMDRevolution Medicines · $41.5B | Reiterated | Buy | $275 | +54.5% | −2.5%next day −4.9% | ↗ |
| Oct 15on TipRanks 07:30 | AXSMAxsome Therapeutics · $8.2B | Reiterated | Buy | $268 | +70.5% | −0.5%next day −1.8% | ↗ |
| Oct 6on TipRanks 07:35 | BIIBSPYBiogen · $34.8B | Reiterated | Buy | $256 | +10.0% | −0.9%next day −0.1% · 5 days +2.8% | ↗ |
| Oct 2on TipRanks 12:35 | BIIBSPYBiogen · $34.8B | Reiterated | Buy | $256 | +10.0% | −2.1%next day +1.0% · 5 days +1.5% | ↗ |
| Oct 2on TipRanks 04:35 | LBRXIWMLB Pharmaceuticals, Inc. · $1.2B | Initiated | Buy | $68.00 | +85.1% | −1.5%next day −7.1% · 5 days −0.5% | ↗ |
| Sep 25on TipRanks Sep 24 09:45 | ACADIWMACADIA Pharmaceuticals · $3.4B | Reiterated | Buy | $41.00 → $35.00−14.6% | +83.1% | −12.7%next day −7.3% · 5 days −9.9% | ↗ |
| Sep 24on TipRanks 06:08 | HRMYIWMHarmony Biosciences Holdings · $2.2B | Reiterated | Buy | $50.00 | +31.8% | +1.8%next day −0.3% · 5 days −3.4% | ↗ |
| Sep 24on TipRanks 05:55 | PRAXIWMPraxis Precision Medicines · $6.9B | Reiterated | Buy | $582 | +140.7% | 0.0%next day −0.9% · 5 days +2.2% | ↗ |
| Sep 21on TipRanks 10:15 | ALKSIWMAlkermes · $6.7B | Reiterated | Buy | $62.00 | +50.4% | +0.3%next day −2.0% · 5 days −8.1% | ↗ |
| Sep 14on TipRanks 08:55 | DFTXIWMDefinium Therapeutics · $4.6B | Reiterated | Buy | $66.00 | +105.6% | +3.9%next day −8.1% · 5 days −4.3% | ↗ |
| Aug 31on TipRanks 08:50 | JAZZJazz Pharmaceuticals · $13.9B | Reiterated | Buy | $310 | +47.5% | +2.8%next day −2.1% · 5 days −4.1% | ↗ |
| Aug 31on TipRanks 07:20 | MPLTIWMMapLight Therapeutics, Inc. · $446M | Assigned | Buy | $45.00 → $43.00−4.4% | +458.4% | +3.2%next day +3.3% · 5 days +7.7% | ↗ |
| Aug 31on TipRanks 05:55 | RVMDRevolution Medicines · $41.5B | Reiterated | Buy | $240 → $275+14.6% | +54.5% | −0.8%next day +2.8% · 5 days +1.0% | ↗ |
| Aug 14on TipRanks 12:30 | NMRAIWMNeumora Therapeutics, Inc. · $80M | Reiterated | Buy | $5.00 | +957.1% | −7.3%next day −4.5% · 5 days +3.2% | ↗ |
| Aug 11on TipRanks Aug 10 18:15 | COGTIWMCogent Biosciences · $4.9B | Assigned | Hold | — | — | −6.5%next day +0.5% · 5 days −3.0% | ↗ |
| Aug 10on TipRanks 08:35 | AXSMAxsome Therapeutics · $8.2B | Reiterated | Buy | $267 → $268+0.4% | +70.5% | +3.9%next day −2.0% · 5 days −2.0% | ↗ |
| Aug 5on TipRanks 16:15 | IMRXIWMImmuneering · $235M | Reiterated | Buy | $11.00 → $18.00+63.6% | +401.4% | +1.8%next day +0.5% · 5 days +15.4% | ↗ |
| Jul 31on TipRanks 05:42 | NBIXNeurocrine · $13.9B | Assigned | Buy | $200 → $204+2.0% | +50.3% | −10.8%next day −1.8% · 5 days −5.5% | ↗ |
| Jul 29on TipRanks 11:43 | BIIBSPYBiogen · $34.8B | Reiterated | Buy | $256 | +10.0% | +3.3%next day −2.3% · 5 days −6.8% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗